ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

ClinicalTrials.gov ID: NCT06383273

Public ClinicalTrials.gov record NCT06383273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Study identification

NCT ID
NCT06383273
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Melt Pharmaceuticals
Industry
Enrollment
528 participants

Conditions and interventions

Conditions

Interventions

  • MELT-300 sublingual tablet Drug
  • Midalozam sublingual tablet Drug
  • Placebo sublingual tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2024
Primary completion
Nov 30, 2024
Completion
Dec 31, 2024
Last update posted
Aug 1, 2024

2024 – 2025

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Ridge Eye Care, Inc. Chico California 95928 Recruiting
Icon Eye Care Grand Junction Colorado 81501 Recruiting
Levenson Eye Associates Jacksonville Florida 32204 Recruiting
Maryland Vision Institute Hagerstown Maryland 21740 Recruiting
Vance Thompson Vision- Alexandria Alexandria Minnesota 56308 Recruiting
Tekwani Vision Center Bay Saint Louis Mississippi 63128 Recruiting
Bergstrom Eye Research Fargo North Dakota 58103 Recruiting
Vance Thompson Vision, ND West Fargo North Dakota 58078 Recruiting
Northeastern Eye Institute Scranton Pennsylvania 18503 Recruiting
Conway Ophthalmology Conway South Carolina 29526 Recruiting
Vance Thompson Vision Sioux Falls South Dakota 57108 Recruiting
Utah Eye Centers- Pleasant Grove Pleasant Grove Utah 84062 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06383273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 1, 2024 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06383273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →